Biomeditsina va amaliyot jurnali, 2022 №5

Тема статьи

EVALUATION OF THE STATE OF THE IMMUNE STATUS IN PATIENTS WITH BREAST CANCER WITH THE DETERMINATION OF THE EFFECTIVENESS OF NEOADJUVANT POLYCHEMOTHERAPY (211-216)

Авторы

Lutfillo Yorov, Mirjalol Djuraev, Nodir Raximov, Shakhnoza Shakhanova

Учреждение

Samarkand State Medical University

Аннотация

Therapy for breast cancer is due to the presence of aggressive biological types of tumors that require multiple, expensive chemotherapy regimens, even in the early stages of the process. In recent years, such a direction as MN immunotherapy has been developing, which is aimed at inhibiting tumor growth and stimulating the body's antitumor immune response. Carrying out immunocorrection in patients with breast cancer with Her-2 positive status has great prospects in oncological practice, due to the possibility of reducing the side effects of tumor and chemoradiation intoxication, as well as activating the own antitumor defense system. Determination of the optimal immunomodulatory drugs, the sequence of various effects on the immune system, and their impact on the results of anticancer therapy require further research.

Ключевые слова

breast cancer, immune status, neoadjuvant polychemotherapy

Литературы

Babayev S.A., Bekturdiev Sh.S, Rakhimov N.M., Jalalova D.Z Yusupova D.Z., Shakhanova Sh.Sh. Assessment of the state of immunity in patients with tumors. Central asian journal of medical and natural sciences. Volume: 02 Issue: 03 | May-June 2021. 2. Laakmann, E., Müller, V., Schmidt, M., & Witzel, I. (2017). Systemic treatment options for HER2-positive breast cancer patients with brain metastases beyond trastuzumab: a literature review. Breast Care, 12(3), 168-171] 3. Schettini F., Pascual T., Conte B., Chic N., Brasó-Maristany F., Galván P., Martínez O., Adamo B., Vidal M. et.al, HER2-enriched subtype and pathological complete response in HER2- positive breast cancer: A systematic review and meta-analysis //Cancer Treatment Reviews, Volume 84, 2020] 4. Song T., Wang Y., Du W., Cao S. et al. The method for breast cancer grade prediction and pathway analysis based on improved multiple kernel learning // J. Bioinform Comput Biol. – 2017 5. Ueno T., Saji S., Chiba T., Kamma H. et al. Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer // Tumour Biol. – 2018. – Vol. 40 (10). – P. 1 – 10; 6. Каримова М.Н., Шаханова Ш.Ш., Саидкулов Б.С., Ахмеджанова Д.П., Нурмамедова И.Г.. Билатеральная лимфосаркома молочных желез (клинический случай из практики). Достижения науки и образования, 2020, 1 (55). Стр 94-100. 7. Ризаев Ж. А., Хазратов А. И. Канцерогенное влияние 1, 2–диметилгидразина на организм в целом //Биология. – 2020. – Т. 1. – С. 116. 8. Shakhanova Shakhnoza, Rakhimov Nodir, Zaripova Parvina. Breast tumors in adolescent girls // Journal of Biomedicine and Practice. 2022, vol. 7, issue 3, pp.266-273 9. Shavkatovna S. S. et al. Breast Pathology in Adolescent Girls //CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES. – 2022. – Т. 3. – №. 3. – С. 66-71.